| MicroRNA-146a: a dominant, negative regulator of the innate immune response R Saba, DL Sorensen, SA Booth Frontiers in immunology 5, 578, 2014 | 391 | 2014 |
| A miRNA signature of prion induced neurodegeneration R Saba, CD Goodman, RLCH Huzarewich, C Robertson, SA Booth PloS one 3 (11), e3652, 2008 | 286 | 2008 |
| Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons R Saba, PH Störchel, A Aksoy-Aksel, F Kepura, G Lippi, TD Plant, ... Molecular and cellular biology 32 (3), 619-632, 2012 | 268 | 2012 |
| microRNAs in neurons: manifold regulatory roles at the synapse G Siegel, R Saba, G Schratt Current opinion in genetics & development 21 (4), 491-497, 2011 | 192 | 2011 |
| MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state R Saba, S Gushue, RLCH Huzarewich, K Manguiat, S Medina, ... PloS one 7 (2), e30832, 2012 | 184 | 2012 |
| MicroRNA abundance is altered in synaptoneurosomes during prion disease AS Boese, R Saba, K Campbell, A Majer, S Medina, L Burton, TF Booth, ... Molecular and Cellular Neuroscience 71, 13-24, 2016 | 123 | 2016 |
| MicroRNAs in neuronal development, function and dysfunction R Saba, GM Schratt Brain research 1338, 3-13, 2010 | 105 | 2010 |
| MicroRNA function in the nervous system R Fiore, S Khudayberdiev, R Saba, G Schratt Progress in molecular biology and translational science 102, 47-100, 2011 | 89 | 2011 |
| Target labelling for the detection and profiling of microRNAs expressed in CNS tissue using microarrays R Saba, SA Booth BMC biotechnology 6 (1), 47, 2006 | 37 | 2006 |
| MicroRNA-16 targets mRNA involved in neurite extension and branching in hippocampal neurons during presymptomatic prion disease K Burak, L Lamoureux, A Boese, A Majer, R Saba, Y Niu, K Frost, ... Neurobiology of disease 112, 1-13, 2018 | 35 | 2018 |
| The emerging use of in vivo optical imaging in the study of neurodegenerative diseases AP Patterson, SA Booth, R Saba BioMed Research International 2014, 2014 | 27 | 2014 |
| MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol. 2014; 5: 578 R Saba, DL Sorensen, SA Booth | 22 | 2014 |
| The genetics of susceptibility to variant Creutzfeldt-Jakob disease R Saba, SA Booth Public Health Genomics 16 (1-2), 17-24, 2013 | 21 | 2013 |
| A Functional SNP Catalog of Overlapping mi RNA‐Binding Sites in Genes Implicated in Prion Disease and Other Neurodegenerative Disorders R Saba, SJ Medina, SA Booth Human mutation 35 (10), 1233-1248, 2014 | 18 | 2014 |
| Small RNA drugs for prion disease: a new frontier AS Boese, A Majer, R Saba, SA Booth Expert opinion on drug discovery 8 (10), 1265-1284, 2013 | 12 | 2013 |
| Polymorphisms affecting miRNA regulation: a new level of genetic variation affecting disorders and diseases of the human CNS R Saba, SA Booth Future Neurology 8 (4), 411-431, 2013 | 6 | 2013 |
| MicroRNA Profiling in CNS Tissue Using Microarrays R Saba, SA Booth Current Perspectives in microRNAs (miRNA), 73-96, 2008 | 1 | 2008 |
| miR-196a: is it the ‘silver bullet’against Huntington’s disease? R Saba, SA Booth Future Neurology 9 (1), 27-31, 2014 | | 2014 |
| Author and Subject Index Vol. 16, No. 1–2, 2013 R Saba, SA Booth, MW Gilmour, M Graham, A Reimer, G Van Domselaar, ... Public Health Genomics 16 (1-2), 73-73, 2013 | | 2013 |
| Delay in prion disease incubation time in transgenic mice with a microRNA-146a gene deletion R Saba, R Huzarewich, S Gushue, B Abrenica, Y Niu, S Booth PRION 6, 63-63, 2012 | | 2012 |
